Apex Bioventures Acquisition Corporation Receives Notice of Extension from NYSE Amex

Apex Bioventures Acquisition Corporation Receives Notice of Extension from
NYSE Amex

HILLSBOROUGH, Calif., May 11 /PRNewswire-FirstCall/ -- Apex Bioventures
Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced today that
it has received notice from NYSE Amex LLC (the "Exchange") that the plan of
compliance submitted by the Company has been accepted by the Exchange and the
Company has been granted an extension until August 11, 2009 to regain
compliance with the continued listing standards of the Exchange.

As reported in a press release dated February 13, 2009, the Company received
notice from the Exchange on February 10, 2009 indicating that the Company is
not in compliance with one of the requirements for continued listing on the
Exchange due to the Company's failure to hold an annual meeting during
calendar year 2008. The Company was afforded the opportunity to submit to the
Exchange a plan of compliance and on March 6, 2009, submitted its plan to the
Exchange.

The Company will be subject to periodic review by Exchange staff during the
extension period. Failure to make progress consistent with the plan or to
regain compliance with the continued listing standards by the end of the
extension period could result in the Company being delisted from the Exchange.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995, as amended.
These statements are based on current expectations and are subject to numerous
risks, assumptions and uncertainties, many of which change over time and are
beyond the Company's control. Actual results may differ materially from those
anticipated in any forward-looking statement and you should not place any
undue reliance on such forward-looking statements. More detailed information
about the Company and risk factors that may affect the realization of
forward-looking statements, including forward-looking statements in this press
release, is set forth in the Company's filings with the Securities and
Exchange Commission. The Company urges investors and security holders to read
those documents free of charge at the Commission's web site at
http://www.sec.gov. Interested parties may also obtain these documents free of
charge from the Company. Forward-looking statements speak only as to the date
they are made, and except for any obligation under the U.S. federal securities
laws, the Company undertakes no obligation to publicly update any
forward-looking statement as a result of new information, future events or
otherwise.

SOURCE Apex Bioventures Acquisition Corporation

Darrell J. Elliott, Chairman and Chief Executive Officer, Apex Bioventures
Acquisition Corporation, +1-604-924-0349, or K. Michael Forrest, President and
Chief Operating Officer, Apex Bioventures Acquisition Corporation,
+1-650-344-3029